A PHASE II RANDOMIZED TRIAL COMPARING A COMBINATION OF ABRAXANE AND GEMCITABINE VERSUS GEMCITABINE ALONE AS FIRST LINE TREATMENT IN LOCALLY ADVANCED UNRESECTABLE PANCREATIC CANCER